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Abstract
A large body of evidence has implicated amyloid precursor protein (APP) and its proteolytic derivatives as key players in the
physiological context of neuronal synaptogenesis and synapse maintenance, as well as in the pathology of Alzheimer’s
Disease (AD). Although APP processing and release are known to occur in response to neuronal stimulation, the exact
mechanism by which APP reaches the neuronal surface is unclear. We now demonstrate that a small but relevant number of
synaptic vesicles contain APP, which can be released during neuronal activity, and most likely represent the major exocytic
pathway of APP. This novel finding leads us to propose a revised model of presynaptic APP trafficking that reconciles
existing knowledge on APP with our present understanding of vesicular release and recycling.
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Introduction
Amyloid precursor protein (APP) is a type 1 membrane-
spanning protein of approximately 120 kDa, which is ubiquitously
expressed in mammalian cells. The protein has received particular
attention because of its role in the nervous system. Under normal
physiological conditions APP is involved in synapse formation and
function. However, it is the involvement of this protein in the
pathology of Alzheimer’s disease that has raised particular interest.
Alzheimer’s disease is the most prevalent neurodegenerative
disease facing western populations. Dysregulation of APP
trafficking is thought to play a central role in the progression of
this condition, because formation of the senile plaques character-
istic of the disease is intimately linked to APP metabolism [1].
As such there is considerable interest in understanding both the
molecular processing and trafficking pathways of this protein in
neurons. Indeed over the last twenty years, these problems have
formed the basis of intensive investigations by a large number of
groups. Unfortunately, while the molecular events surrounding
APP processing have been comprehensively elucidated, the
cellular mechanisms regulating its intracellular trafficking in
neurons remain unclear.
To date, the most widely accepted model of APP trafficking in
the presynaptic terminal is one put forward by Cirrito and
colleagues [2]. This integrates results from their own in vivo
microdialysis experiments with knowledge of APP transport in
tissue culture cells to present a model of synaptic trafficking
consistent with the known molecular processing of this protein. In
this model, full-length APP is constitutively transported from the
ER-Golgi network to the cell surface, where cleavage by a-
secretase results in the release of a 100–110 kDa soluble fragment
(sAPPa), which plays a crucial role in synapse formation and
maintenance [3]. However, only a fraction of APP is thought to be
cleaved at the cell surface and the protein can be further processed
by internalization, via clathrin-mediated endocytosis, to an early
endosomal compartment [2]. Here, the molecule is cleaved by the
sequential actions of beta site APP cleaving enzyme 1 (BACE 1)
and the c-secretase complex to produce a soluble N-terminal
fragment (sAPPb) and a 37–49 amino acid amyloid b-peptide (Ab)
– the so-called ‘amylogenic pathway’ [4]. Once produced, these
protein fragments are trafficked back to the plasma membrane for
subsequent secretion [5]. In the brain sAPPb promotes axonal
pruning via caspase activation [6]. Ab-oligomers inhibit long-term
potentiation, suggesting an important role in modulating synaptic
plasticity and synaptic scaling under physiological conditions,
where the levels of Ab are controlled by regulation of both
production and degradation. It is overproduction of Ab,
commonly due to mutations in APP or its processing enzymes,
that is considered to act pathologically, leading to concentration-
dependent formation of amyloid plaques, neurotoxicity and
synapse loss [7]. The remaining amino-terminal APP intracellular
domain (AICD) may serve as a transcription factor [8].
Interestingly, formation of sAPPa and sAPPb/Ab are thought to
be mutually exclusive, as cleavage by a-secretase occurs within the
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eBACE recognition site, allowing potential modulation of the
amylogenic pathway. A more detailed description of the molecular
processing of APP and its functions can be found in reviews that
have recently been published [9,10].
Unfortunately, investigating the trafficking of APP in neurons,
in particular its role within the secretory apparatus, has always
been complicated by two major factors. First, endogenous APP is
expressed at very low levels, typically at the limit of assay
sensitivity, in both rat and mouse neurons [11]. Hence the usual
approach to studying APP in neurons has been based on
overexpression of the protein, either acutely in culture conditions
or chronically in transgenic mouse models, even though the
exogenous protein may not always traffic correctly when expressed
at high levels. Second, techniques such as microdialysis do not
directly assess presynaptic trafficking pathways, as they only
measure the terminal event (release) – explaining the reliance on
data obtained from tissue culture cell models [2]. Thus, some
intriguing details have remained elusive, which have hindered
attempts to draw a completely integrated pathway for APP
trafficking at the synapse. For instance, although endogenous full-
length APP was found in clathrin-coated vesicles, which represent
the main recycling pathway for synaptic vesicle recycling in brain,
it was proposed that APP is sorted away from synaptic vesicle
proteins during the recycling process [12]. Given that synaptic
vesicle proteins are generally thought to enrich to the vesicle, the
small amount of APP found in purified synaptic vesicle fractions
has, therefore, generally been regarded as a contaminant - and it
became accepted that APP (derivatives) are not released during
exocytosis of synaptic vesicles. Thus, the exact identity of the
secretory organelle remains enigmatic, despite the fact that Ab
release has many of the hallmarks of synaptic vesicle release and
recycling (including sensitivity to tetrodotoxin, tetanus toxin and
dynamin inhibitors) [2,5].
Recently, however, Frykman and colleagues found that c-
secretase is highly enriched in a crude synaptic vesicle fraction,
together with APP cleavage products [13]. And, much to our
surprise, we also found APP in a fraction of highly pure synaptic
vesicles during a routine proteomic analysis aimed at finding
novel proteins that may play a role in regulating neurotransmis-
sion - and whose dysfunction may thus lead to a role in
neurological disease. Encouraged by these findings, as well as by
recent advances in technology, we decided to reinvestigate the
trafficking of APP in neurons, using established biochemical
techniques in conjunction with new developments in optical
methods that allow direct, real-time measurement of protein
trafficking in the presynaptic terminal. Here we present data that
unambiguously shows endogenous APP to be present at low levels
in synaptic vesicles, which undergo stimulation-dependent exo-
and endocytosis. Given the number of synaptic vesicles per
terminal and the frequency of vesicle cycling, this mode of release
can easily account for the majority of APP (derivatives) secreted
into the synaptic cleft. Further, we integrate this finding into a
revised model for APP trafficking, which fully reconciles the
existing data on APP with our current understanding of vesicular
release and recycling, in line with the central role of this protein
in synaptic function and disease pathology. Finally, we briefly
speculate on the implications of our model for the future
generation of therapeutics aimed at combating Alzheimer’s
disease.
Materials and Methods
Full details of all procedures (including antibodies) can be found
in Methods S1.
Biochemical Procedures
Purification of synaptic vesicles. Synaptic vesicles were
purified according to standard protocols [14,15]. Briefly, synaptic
vesicles were released from synaptosomes by osmotic lysis, and
were further purified by rate-zonal sucrose gradient centrifugation
and a final step of size exclusion chromatography on controlled
pore glass beads.
Mass Spectrometry. Approximately 10–20 mg of synaptic
vesicle proteins were separated by 1D SDS-PAGE using a
tricine mini-gel [16]. After coomassie staining, lanes were cut
into bands and subjected to in-gel trypsinization. Extracted
peptides were analyzed by liquid chromatography-coupled MS/
MS on an Orbitrap machine (Thermo) and proteins were
identified in the National Center for Biotechnology Information
(NCBI) non-redundant database using MASCOT software as a
search engine [15].
Western Blotting. Proteins were separated using a tricine
based gel system (as above). Proteins were then transferred to
nitrocellulose membrane using standard semi-dry techniques [17].
Membranes were blocked and incubated with primary antibodies
overnight at 4uC. HRP-conjugated secondary antibodies were
added for one hour at room temperature. Blots were developed
using Western Lightning chemiluminescence reagents and images
acquired using a CCD reader.
Immungold electron microscopy. Electron microscopy
was performed as previously described with minor modifications
[18]. Synaptic vesicles were absorbed to formvar-coated grids,
fixed with 1% paraformaldehyde, quenched with 20 mM glycine
and immunostained for synaptophysin and APP. Detection was
performed with Protein A-gold. To avoid possible steric masking
of APP as a result of synaptophysin staining, a sequential protocol
was employed in which APP was labeled first. This was blocked
using 1% glutaraldehyde, and then synaptophysin labeling was
performed. After counterstaining with 1% uranylacetate, samples
were viewed using a CM120 electron microscope, equipped with a
TemCam 224A CCD camera.
Imaging Procedures
Cell culture. Hippocampal neurons of the CA3/CA1 region
from 1- to 3 day old Wistar rats were prepared in a sparse culture
(2,000–5,000 cells per coverslip), and transfected after 3–4 days in
vitro (DIV) using a modified calcium phosphate transfection
procedure. Microscopy was performed at 14–21 DIV [19].
4Pi nanoscopy. Cells were covered with 20 ml of buffer and
sealed with a second coverslip coated with sub-resolution red
fluorescent beads for focal adjustments (TransFluoSpheres,
NeutrAvidinTM labeled microspheres, 0.1 mm diameter;
excitation maximum 488 nm, emission maximum 605 nm). The
space between the two coverslips was always less than 30 mm.
Images were obtained with a commercial 4Pi microscope (Type A-
TCS 4Pi, Leica Microsystems).
Plasmid constructs. A pHluorin-synaptotagmin-1 vector
construct [20] was used to fuse pHluorin N-terminally to an APP
cDNA. The APP cDNA (APP695) was obtained by preparation of
total RNA from rat brain, subsequent reverse transcription and
cDNA amplification by PCR. Primers were designed to include
additional recognition sites for Bsu36I and NotI, to allow
subsequent cloning of the APP cDNA fragment into the vector
after excision of the synaptotagmin-1 cDNA. The sequence of the
forward primer was 59-cctgaggcggatcttccactcgcacac-39; the reverse
primer sequence was 59-gcggccgcgtcaaaagccgagggtgagtaaat-39. The
integrity of the pHluorin-APP construct was verified by sequencing.
Antibody labeling of recycling synaptic vesicles.
Antibody labeling was performed with antibodies against
APP in Synaptic Vesicles
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on pHluorin-APP transfected hippocampal neurons, by incubating
the neurons with antibody for 3–4 hours at 37u in a bicarbonate
buffer containing (in mM) 120 NaCl, 5 KCl, 1 MgCl2, 2.5 CaCl2,
10 glucose, 18 NaHCO3; pH 7.4 was maintained using 5%
atmospheric CO2. The cells were then washed twice and placed in
a perfusion chamber containing Tyrode solution for imaging.
Epifluorescence microscopy of living neurons. Imaging
was performed as described previously [20]. A modified Tyrode
solution (in mM; 150 NaCl, 4 KCl, 1 MgCl2, 2 CaCl2, 10 glucose,
10 HEPES buffer, pH 7.4 NaOH) was used for all experiments
unless otherwise indicated. Synaptic boutons were stimulated by
electric field stimulation (platinum electrodes, 10-mm spacing, 1-
ms pulses of 50 mA with alternating polarity). 10 mM CNQX and
50 mM AP5 were added to the bath solution to prevent recurrent
synaptic activity as a result of AMPA receptor activation. Fast
solution exchanges were achieved using a piezo-controlled stepper
device, with a three-barrel glass tubing. The perfusion rate during
the experiments was kept at a constant 1 ml/min. To block
reacidification of freshly recycled synaptic vesicles, 65 nM
folimycin was applied to the neuronal culture before the
experiment. For dequenching of vesicular pHAPP, ammonium
chloride solution (pH 7.4) was prepared by equimolar substitution
of 50 mM NH4Cl for NaCl in the Tyrode solution. All other
components remained unchanged.
Imaging was performed usinga cooled CCD cameramounted on
a Zeiss Axiovert 135TV microscope equipped with a 606, 1.2 NA
water-immersion objective and a FITC/Cy5 dual-band filter set.
Excitation wavelengths of 480 nm (pHAPP) and 640 nm (cypHer)
were produced by a computer-controlled monochromator.
Ethics statement
All tissues used in this study were obtained from Wistar rats
(Charles River, USA), bred and kept for experimental purposes at
the Max Planck Institute for Biophysical Chemistry by authori-
zation of the federal state of Lower Saxony, Germany (licence Az.
32.22/Vo). The killing of rats for tissue preparations is not an
animal experiment under the terms of federal animal protections
laws, so approval by an ethics committee was not necessary.
However, all experiments involving the use of animals were
carried out following the stringent guidelines issued by the Max
Planck Institute, to ensure the highest standards of animal welfare.
Results
A routine mass-spectrometry screen detected APP in a
preparation of isolated synaptic vesicles
Although our laboratories recently completed a detailed
proteomic analysis of the synaptic vesicle, several known (mem-
brane) proteins were not identified, including the chloride channels
ClC3 and ClC7, as well as the vesicular neurotransmitter
transporters responsible for monoamine (VMAT) and acetylcholine
(VAChT) uptakeintovesicles[15]. Difficultiesinmass-spectrometry
based proteomic analysis usually result from the low abundance of
the protein in question, or from the general hydrophobicity of
membrane proteins (including the inefficiency of trypsin cleavage).
The major strategies currently used to improve peptide sequence
coverage include improving the initial fractionation steps (such as
protein extraction and the use of different gel types for
electrophoresis), analyses using different mass-spectrometer types
and repeated analysis of the samples, which together can improve
coverage by 20–30% [21]. We decided to reanalyze our synaptic
vesicle preparation, in an attempt to find these ‘‘missing’’ proteins,
using a new, highly sensitive OrbitrapH machine [22]. For initial
screens, we used 1D SDS-PAGE followed by trypsin digestion, as it
is generally the most reliable and robust method used to process
proteins prior to mass-spectrometry [23]. As predicted, when we
searched our peptide list against all entries in the NCBI non-
redundant database, we routinely found the most hydrophobic
protein in synaptic vesicles (the vesicular ATPase subunit c; as
predicted by its Grand Average Hydropathicity (GRAVY) score).
Furthermore, we also startedto find low abundanceproteins such as
the vesicular acetylcholine transporter. In addition, we also
sequenced a peptide at approximately 100 kDa on the gel that
corresponded to amyloid precursor protein (APP). The peptide
(ISYGNDALMPSLTETK with an oxidized methionine) maps to
amino acids 586–601 of APP. Importantly, this peptide had a
Mascot score of 67, indicating that it is highly unlikely that APP was
a false-positive identification (see Methods). However, neither of the
APP processing enzymes BACE nor Presenilin 1 (a component of
thec-secretasecomplex)wasfoundbymass-spectrometry(Figure1).
Immunoblotting proves that APP is present in highly
purified synaptic vesicles
Given that APP is a large protein, containing a large number of
potential trypsin cleavage sites and is reasonably hydrophilic (as
judged by its GRAVY score), we hypothesized that APP is difficult
to detect in synaptic vesicles by mass-spectrometry because it is
present in low amounts, consistent with previous studies, which
found low levels of APP in rodent brain [11]. Therefore, as an
independent means of verification and to compensate, at least in
part, for the non-quantitative nature of our proteomic analysis, we
monitored the distribution of APP using the complimentary
technique of immunoblotting. Analysis of subcellular fractions
using our standard marker proteins synaptophysin (an integral
membrane protein specific for synaptic vesicles) and the NMDA
receptor (a component of the post-synaptic density) revealed that
the preparation was enriched in presynaptic synaptic vesicles
(Figure 1) [15]. Full-length APP was mostly found in fractions
containing endosome-type structures and fragments of plasma
membrane as previously reported (fractions S2 and Peak 1 in
Figure 1; see legend for further definitions). However, the protein
was also found to co-purify at much lower levels with highly pure
synaptic vesicles (SV). This result was confirmed using two
independent antibodies, specific for either an epitope located at
the N- or C-terminal end of the protein; both antibodies showed a
similar distribution profile of APP amongst the fractions. The
doublet staining found in some fractions reflects the differential
glycosylation states of the protein; only fully glycoslyated protein,
which is the predominant species found in the synaptic vesicle
fraction, is thought to be secreted from the neuron [24].
Importantly, this co-purification pattern was consistently occurring
in at least seven full immunoblots, performed using three
independent synaptic vesicle preparations. Interestingly, the APP
processing enzymes BACE 1 and Presenilin 1 were also routinely
found at low levels in the vesicle fraction by immunoblotting; the
absence of BACE signal from relatively impure fractions, such as
synaptosomes, presumably results from it being present at
undetectably low levels, and/or from ‘steric masking’ by tubulin,
which is an abundant cytoskeletal protein that runs at the same
molecular weight as BACE during SDS-PAGE, but is eventually
purified away from synaptic vesicles during the procedure.
The predominant fraction of intracellular APP is thought to be
localized to the endoplasmic reticulum, Golgi apparatus and early
endosomes; the localization of APP to these biosynthetic organelles
being partly explained by the very high rate of synthesis and
turnover of this protein (t1/2 1 hr). Immature APP is localized
exclusively to the ER, and only mature APP that has been N- and
APP in Synaptic Vesicles
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sorting at the TGN [24]. Given the known problems with
preparing subcellular fractions free of contamination, it could
indeed be that the full-length APP found in the synaptic vesicle
fraction actually resulted from low levels of contamination by small
membranes originating from these alternate sources. To exclude
this possibility, immunoblots for compartment specific markers -
GM130 (cis-Golgi), TGN38 (trans-Golgi network) and protein
disulfide isomerase (PDI; endoplasmic reticulum) - were per-
formed. None of these proteins were readily detectable in the
synaptic vesicle fraction by immunoblotting, nor were they
detectable by mass-spectrometry (Figure 1). (See Methods S1 for
a list of antibodies and further details).
Immunoflourescence labeling of neurons shows a
fraction of APP localizing to the synaptic vesicle cluster
To independently confirm the presynaptic localization of APP
we chose to perform immunolabeling on cultured hippocampal
neurons, which are an established system for the study of neuronal
polarity and structure [20,25,26]. Hippocampal neurons were
double immunolabeled for APP and the bona fide synaptic vesicle
marker synaptotagmin 1. Stainings were subsequently imaged
using 4 Pi nanoscopy, which provides an improved spatial
resolution of approximately 20062006160 nm (x, y, z)
(Figure 2). The APP antibody mainly stained elongated structures
that occurred throughout the neurons, and presumably represent-
ed APP transport vesicles [27]. However, a fraction of the
antibody also labeled synaptic boutons, as judged by co-
localization with synaptotagmin 1. Given the increased resolution
of the 4Pi nanoscope these structures were unlikely to be large
synaptic endosomes, but more likely represent synaptic vesicles
containing a small reservoir of APP.
APP and synaptophysin co-localize on purified synaptic
vesicles as revealed by immunogold electron microscopy
Although our biochemical and nanoscopy data are in
agreement with previous work [12,13], the techniques themselves
are rather indirect. Although laborious, the only method presently
capable of visualizing individual synaptic vesicles is electron
microscopy. Hence, to directly confirm the localization of APP to
synaptic vesicles we performed negative stain immunogold
electron microscopy on our isolated synaptic vesicle fraction
[18]. Given that the release of processed APP from a synaptic
vesicle by exocytosis (either in the form of sAPPa or Ab) would
require the N-terminal end of the protein to be orientated towards
the lumen of the vesicle, it is the C-terminal end of the protein that
should be most accessible to antibody labeling on the intact vesicle.
Hence, immunolabeling was performed with only the C-terminal
APP antibody. To overcome potential under-sampling, caused by
the low level of APP in synaptic vesicles, many vesicular profiles
were counted to ensure relevance (3,677 profiles for APP labeling
and 820 profiles for negative control experiments). Figure 3
confirms that the synaptic vesicle preparations used in mass-
spectrometry and immunoblotting were of exceptional purity and
directly localizes APP to synaptophysin-positive synaptic vesicles
(see Figure S1 for controls and single labeling experiments). The
preparation consisted solely of small membraneous profiles, with
diameters in the range of 40–50 nm [15]. None of the vesicles
appeared to be surrounded by electron dense material indicative of
a clathrin coat, consistent with our immunoblotting data (Figure 1).
The lack of a clathrin coat was confirmed by the fact that antibody
labeling would otherwise have been sterically hindered [28].
Approximately, 10% of these vesicles were immunopositive for
APP. Similar results were also obtained when synaptic vesicles
were double labeled with APP and synaptophysin.
When considering that the vesicle fraction we used for our
biochemical analysis represents an ensemble of vesicles isolated
from whole rat brain, it is possible that our results actually under-
represent the number of APP containing vesicles in distinct
neuronal regions, such as the hippocampus [29], which are known
to be particularly susceptible to amylogenic disease.
Transiently overexpressed APP traffics to synaptic
vesicles: Stimulation dependent exocytosis of
pHluorin-APP occurs at synaptic boutons defined by
uptake of a cypHer5E-anti-synaptotagmin 1 IgG
Although immunoblotting and mass spectrometry indicate that
neuronal clathrin light chain is absent from our synaptic vesicle
preparation (Figure 1), we could not definitively exclude that our
synaptic vesicle fraction actually contained a small number of
endocytic vesicles, which had merely lost their coats during
purification [28]. Although clathrin-mediated endocytosis is
Figure 1. Endogenous full-length APP localizes to isolated
synaptic vesicles. APP and its associated processing enzymes were
found in a preparation of highly pure synaptic vesicles isolated from rat
brain by immunoblotting and mass-spectrometry. Fractions were taken
during the preparation of synaptic vesicles by a classical subcellular
fractionation protocol. The fractions shown represent increasing levels
of purification (left to right): whole brain homogenate (H), large cell
fragments and nuclei (P1), crude cytosol - small cell fragments including
microsomes, small myelin fragments and soluble proteins (S2), isolated
nerve terminals ‘synaptosomes’ (P2), nerve terminal plasma membrane
(LP1), crude synaptic vesicles (LP2), presynaptic cytosol (LS2), first peak
from the size exclusion column containing larger membranes ,100–
200 nm (Peak1) and highly pure synaptic vesicles (SV). 10 or 20 mgo f
total protein from each of the individual fractions were subjected to
SDS-PAGE followed by immunoblotting. Fully glycosylated APP was
routinely found in synaptic vesicles by immunoblotting, as were the
APP processing enzymes BACE and Presenilin 1. The neuronal specific
isoform of clathrin light chain was undetectable. Contamination by ER-
Golgi trafficking vesicles was assessed by immunoblotting for GM130
(cis-Golgi), TGN38 (trans-Golgi network) and protein disulfide isomerase
(PDI; Endoplasmic Reticulum). The synaptic vesicle fraction was free of
contamination by these proteins. The column MS gives the results
obtained from mass-spectrometry using the synaptic vesicle fraction.
Proteins found in the SV fraction are indicated with filled circles;
proteins not found in the SV fraction are indicated with empty circles.
doi:10.1371/journal.pone.0018754.g001
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in neurons [30] and clathrin coated vesicles are reported to be a
major source of vesicular APP [12], it has previously been
suggested that vesicle components and APP are separated with
100% efficiency in a sorting intermediate, prior to synaptic vesicle
reformation [12]. Although there is increasing evidence that
biological trafficking pathways, including synaptic vesicle endocy-
tosis, do not sort protein with 100% efficiency [15,31,32], we
sought to exclude, as far as possible, that our APP-positive
structures were merely ‘de-coated’ vesicles.
We reasoned that bona fide synaptic vesicles should undergo
stimulation-dependent secretion from neurons. Therefore, we
were interested to know how APP-positive vesicles behave under
physiological conditions; for instance, do these vesicles undergo
exocytosis, or are they refractory to release? Answering this
question required the use of an assay that allowed direct
visualization of exocytosis in the nerve terminal. For this reason,
we again turned to cultured hippocampal neurons, which have
been extensively used for the study of synaptic transmission using
optical methods [25]. APP constructs (using genetically encoded
fluorescent tags) have been extensively reported as mimicking the
trafficking of the endogenous protein (including its proteolytic
processing), following transient overexpression in cultured
neurons [33,34,35,36]. We followed a similar strategy and cloned
the 695 amino acid isoform of APP, which is the predominant
form found in the nervous system [37], from a rat brain RNA
library and attached an N-terminal pHluorin tag to create
pHluorin APP (pHAPP). pHluorins are pH sensitive variants of
GFP which have been tagged to specific synaptic vesicle proteins
and used to quantify synaptic vesicle exo- and endocytosis
[25,38]. Briefly, pHluorin marker systems make use of the fact
that the vesicular lumen is acidic – proton transport across the
vesicle membrane produces the electrochemical gradient needed
for neurotransmitter uptake. In the acidic pH of the vesicular
lumen pHluorins are quenched, and only become fluorescent
when they are exposed to the more alkaline pH of the external
culture media, as a result of exocytosis. The fluorescence signal
then recovers following cessation of stimulation as vesicular
membranes and proteins are recovered by endocytosis, and
synaptic vesicles are reformed and re-acidified. (A schematic of
the use of a pHluorin construct in monitoring synaptic activity is
given in Figure S2. See also Materials and Methods). As massive
overexpression of APP can lead to changes in the APP trafficking
pathway, we decided to use the more moderate, neuron-specific
synapsin promoter to drive pHAPP expression. Recent work by
our group has shown that this promoter only drives the
incorporation of 1 or 2 proteins into each vesicle when
synaptobrevin 2-pHluorin is transiently overexpressed in hippo-
campal neurons cultured from a synaptobrevin 2 knock-out
animal (despite synaptobrevin 2 being present, on average, at
over 60 copies per vesicle in wild-type animals; Sinha et al.,
submitted). Nevertheless, the overall change in fluorescence
recorded during stimulation of neurons expressing synaptobrevin
2-pHluorin is still more than two orders of magnitude greater
than that recorded for pHAPP (data not shown), implying that
pHAPP is incorporated into only a fraction of vesicles in the
synaptic terminal, entirely consistent with our data on endoge-
nous APP sorting (Figures 1, 2, 3).
Hippocampal neurons in culture that express pHAPP show very
little surface fluorescence (Figure 4), although it is unclear whether
this is because pHAPP delivered to the cell surface is efficiently
cleaved or endocytosed, or whether pHAPP is exclusively
trafficked via an alternative internal pathway. In any case, lack
of surface expression made it difficult to correctly identify
transfected neurons above background auto-fluorescence
(Figures 4A and B). To overcome this problem, we adopted a
Figure 2. Immunolabeling of fixed hippocampal neurons for APP assessed using 4Pi nanoscopy. Localization of APP to the presynaptic
terminal was initially confirmed by double immunofluorescence labeling of cultured hippocampal neurons. Synaptic boutons were detected by
immunostaining for the bona fide synaptic vesicle protein synaptotagmin 1 (Syt1), using an antibody that binds the N-terminal (luminal) domain of
the protein. For APP staining, an antibody directed against the C-terminus of the protein was used. Relative protein distributions were assessed using
4Pi nanoscopy. (A) 4Pi nanoscopy images (upper row: xy- projections, lower row: xz-projections) of neuronal processes stained for synaptotagmin
and APP. The APP antibody stained punctate structures that were often elongated in shape, presumably representing APP-transport vesicles.
However, some puncta also co-labeled synaptic boutons (see B), as identified by the marker synaptotagmin (coverslips N=9; synaptic boutons
n=113). (B) Detailed images from (A), corresponding to the area marked by the white box. Synaptotagmin positive presynaptic boutons showed a
diffuse APP staining throughout most of the vesicle cluster, suggesting that a small proportion of presynaptic APP is localized to synaptic vesicles.
Scale bars 1 mm.
doi:10.1371/journal.pone.0018754.g002
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synaptic terminals were co-labeled with a monoclonal antibody
against the intra-vesicular domain of the synaptic vesicle protein
synaptotagmin 1. Following exocytosis, the intra-vesicular domain
of synaptotagmin becomes accessible and can be labeled with an
antibody, which is then internalized when the vesicles are retrieved
[39]. The monoclonal antibody was coupled to the pH-sensitive
Cy-5 dye variant cypHer 5 [40,41], which can be spectrally
separated from pHAPP. Importantly, cypHer fluorescence shows
an inverse profile to that of pHluorin, being fluorescent only in the
acidic environment of the vesicle following endocytosis (see Figure
S2). Together these two markers provide information on both exo-
and endocytosis in neurons.
Using this dual labeling strategy, active boutons could be
unequivocally identified by the uptake of the cypHer 5 labeled
antibody against synaptotagmin1 (aSyt1-cypHer) during vesicle
recycling. We thus defined active synaptic boutons as aSyt1-
cypHer positive regions and analyzed the corresponding loci in the
pHAPP channel. In resting neurons, APP surface fluorescence was
co-localized to synaptic boutons labeled with aSyt1-cypHer in
only a limited number of regions (Figure 4A). However, when
neurons were stimulated electrically (30 s, 20 Hz), pHAPP
fluorescence was basically limited to aSyt1-cypHer positive sites
(Figure 4B), as judged by the high degree of statistical correlation
between the two signals (Spearman’s rho=0.63, p,0.001)
(Figure 4C). Importantly, the increase in pHAPP fluorescence
was time-locked to the start of stimulation and the overall time
course of pHAPP fluorescence mirrored that of aSyt1-cypHer
(Figure 4D), suggesting that pHAPP is a synaptic vesicle protein,
which cycles in an activity-dependent manner. As an additional
control, we also tested whether the decrease of pHAPP
fluorescence at the end of stimulation was due to vesicular re-
acidification by applying the selective proton pump inhibitor
folimycin (N=6, n.400) [42]. Here the dual marker approach
had the additional advantage of confirming the folimycin effect on
aSyt1-cypHer kinetics. We found that folimycin inhibited the
decrease in pHAPP-fluorescence seen on the cessation of
stimulation (Figure 4E) and conclude both that pHAPP traffics
to synaptic vesicles and that at least a fraction of the protein is
subject to stimulation dependent exocytosis and compensatory
endocytosis.
A fraction of pHluorin-APP is lost from synaptic vesicles
during rounds of exo- and endocytosis
While the above data proves that at least a fraction of full-length
pHAPP recycles with synaptic vesicles it cannot be discounted that
some pHAPP is cleaved during vesicle cycling, particularly
considering that the processing enzymes BACE and Presenilin 1
Figure 3. APP and synaptophysin co-localize on a fraction of synaptic vesicles. Synaptic vesicles isolated from rat brain were
immunolabeled for synaptophysin (Syp), APP or double labeled (Syp 5 nm gold; APP 10 nm gold), before viewing by negative stain electron
microscopy. The low magnification images show the synaptic vesicle preparation to consist solely of small, homogeneously shaped vesicles, with
diameters in the range of 40–50 nm. Single labeling resulted in 99% of all vesicles immunopositive for synaptophysin (as previously reported) and
10% of all vesicles immunopositive for APP. Similar results were obtained with double labeling; a double labeled vesicle can clearly be seen in the
magnified view. In all images, APP labeling is indicated using arrowheads. For single labeling experiments n=3; for double labeling experiment n=2.
Scale bars, low magnification 100 nm; high magnification 50 nm.
doi:10.1371/journal.pone.0018754.g003
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the context of exo- and endocytosis, this would result in the loss of
the N-terminal fluorescence label on pHAPP following electrical
stimulation (Figure S2 A, ‘Cleavage’). Ammonium chloride is
membrane permeable and will neutralize the pH of the vesicle
lumen; hence, when applied systemically, ammonium chloride will
report the entire pHluorin content of the synaptic terminal (Figure
S2 A, ‘NH4’) [25]. Hence we applied short pulses of ammonium
chloride before and after electrical stimulation (45 s, 20 Hz). In
order not to induce fluorescence decrease by photobleaching we
limited the recordings of pHAPP fluorescence to the ammonium
applications (Figure 5A). We found the ammonium-induced
pHAPP fluorescence decreased significantly after electrical
stimulation (Figures 5B and C). We conclude that the fluorescence
loss reflects cleavage of the APP construct C-terminal to the
pHluorin tag and subsequent loss into the extracellular medium; in
a perfused cell culture system, such as ours, secreted molecules or
peptides will be removed in milliseconds from the synaptic cleft.
Figure 4. pHluorin-APP and aSyt1-cypHer co-localize at sites of synaptic activity and accurately report synaptic activity. A)
Unstimulated neurons showed a punctate staining pattern when labeled with either aSyt1-cypHer or pHAPP. pHAPP staining was typically at the
detection limit of the system. Overlaying the images showed that pHAPP partly co-localized with aSyt1-cypHer, which also stained untransfected
neurons. Note, consistent with the high rate of synthesis and turnover of APP in neurons, pHAPP also seemed to be concentrated in the Golgi
compartment of the neuron. B) Comparison of baseline images (F0) and difference images calculated by subtracting the image taken before
stimulation from the image taken after stimulation (dF). dF is positive at loci where fluorescence increases upon stimulation (exocytosis) (see also D).
As seen in dF images, exocytosis is confined to aSyt1-cypHer positive regions (arrowheads). Images were taken from the region of interest in (A).
Stimulation was 30 s, 20 Hz. The boxed region (dashed) in both images illustrates background fluorescence; however, as background fluorescence
does not increase upon stimulation it is effectively removed in the difference (dF) image. C) Changes in pHAPP fluorescence (dF) were highly
correlated to changes in aSyt1-cypHer fluorescence (arbitrary units). Significance was assessed using a Spearman’s rank order test (N=6; n=383). D)
Time course of fluorescence changes at aSyt1-cypHer positive spots. Synapses labeled with both pHAPP and aSyt1-cypHer show characteristic
fluorescence changes upon electrical stimulation (30 s, 20 Hz). Following cessation of the stimulus, fluorescence recovered to pre-stimulus values
(average of N=7 regions, each comprising n.50 boutons; error bars are SEM). E) Folimycin prevented fluorescence recovery at the end of the
stimulation. Folimycin is a vacuolar-ATPase inhibitor that blocks the reacidification of synaptic vesicles following endocytosis, proving that pHAPP
and aSyt1-cypHer are recovered into synaptic vesicles (average of N=7 regions, each comprising n.50 boutons; error bars are SEM).
doi:10.1371/journal.pone.0018754.g004
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correct proteolytic cleavage of APP-GFP constructs [36], and the
fact that analysis of pHAPP fluorescence following exocytosis
revealed only limited loss through lateral diffusion in the plasma
membrane from synaptic sites into adjacent axonal segments (data
not shown).
Discussion
APP is a bona fide synaptic vesicle protein
In this work we reinvestigated the subcellular localization of
APP in neurons. Using techniques that allowed direct access to
presynaptic mechanisms, we consistently found that small amounts
of APP are present in synaptic vesicles, which undergo activity
dependent secretion.
At first glance, our findings might seem controversial; over the
past decade it has become dogma that APP is absent from synaptic
vesicles, and this has heavily influenced the prevailing view of APP
trafficking in neurons. However, when we revisited the original
literature, we found our results to be entirely consistent with earlier
work. In these studies, immunoblotting showed a small fraction of
APP was found in isolated synaptic vesicles, and partial co-
localization of APP and synaptophysin was demonstrated at the
light microscopy level [12,43]. This was in direct contrast to the
Figure 5. A fraction of pHAPP-fluorescence is lost during electrical stimulation. A) Schematic diagram detailing the time course
experiments used to determine total pHAPP at the synapse. pHAPP content (arbitrary flurescence units) was determined before (dF1) and after
electrical stimulation of neurons (dF2), by application of NH4Cl. Note there was a delay between the cessation of stimulation and application of the
second ammonium pulse (illustrated by the broken time axis between 60 s–300 s), to allow completion of endocytosis and reuptake of pHAPP. Loss
of pHAPP fluorescence (ddF) was calculated as the absolute difference between dF1 and dF2. To minimize photobleaching, image acquisition in the
pHAPP channel was limited to the time during ammonium pulses. Periods of NH4Cl addition and electrical stimulation are illustrated by bars on the
time axis. aSyt1-cypHer5 fluorescence (arbitrary units) was used as an independent reporter of neuronal activity between the ammonium pulses.
Control experiments were performed in an identical fashion, except stimulation was omitted from the protocol. B) Individual boutons show a
significant reduction in the absolute NH4Cl-induced fluorescence increase following electrical stimulation (30 s, 20 Hz) (p=0.0013, paired t-test, N=4,
n=482; t-test performed on N). C) The absolute difference in fluorescence between the two NH4Cl pulses (ddF) was normalized by expressing as a
function of the total pHAPP in the bouton at the start of the experiment (dF1), to take into account slight differences in expression levels from
experiment to experiment. Normalized ddFs obtained under control (grey) and stimulated (black) conditions are plotted as population histograms.
Values for control experiments are centered on 0, indicating little, or no overall loss of fluorescence from the terminal. In contrast, stimulation resulted
in a shift to 0.5, indicative of fluorescence loss.
doi:10.1371/journal.pone.0018754.g005
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below). Given that ‘essential’ trafficking proteins are present in
high numbers on all synaptic vesicles (for example, an average rat
synaptic vesicle is thought to contain over 60 copies of
synaptobrevin 2), it is understandable that the general trend has
been to consider only these proteins as bona fide functional
components [15]. However, both Marquez-Sterling and Ikin
emphasized that they could not necessarily exclude APP being a
synaptic vesicle component. Our pHluorin-cypHer based exper-
iments now provide strong evidence that APP does actually
undergo stimulation-dependent exo- and endocytosis in a small
number of synaptic vesicles, explaining the finding that synaptic
activity and clathrin-dependent endocytosis are associated with
APP trafficking at the synapse [2,5]. Unfortunately, while our
biochemical work also showed APP to be localized to a small
subset of synaptic vesicles (and presumably present in low copy
number) we were unable to obtain any evidence for APP being
localized to distinct functional pools of vesicles in the synaptic
terminal (although this may also be related to subtle trafficking
issues with the construct – see below).
An important remaining question concerns how much APP is
actually released by exocytosis of synaptic vesicles. Previously, it
was thought that the Ab-peptides formed from APP processing
were secreted from exosomes in the neuron. However, this form of
release was found to account for only 1% of the total peptide
secretion [44]. Thus, while there is evidence that these organelles
are secreted by neuronal activity, their overall number and
contribution to release is minor when compared to synaptic vesicle
turnover [45]. Given the number of synaptic vesicles per terminal
and the frequency of vesicle cycling [46] we think it is likely that
this mode of release actually accounts for the vast majority of APP
(and its derivatives) secreted into the synaptic cleft - potentially
providing the missing link between synaptic activity and
extracellular Ab levels.
A revised model of APP trafficking at the synapse
Identifying the synaptic vesicle as a secretory organelle for APP
closes the trafficking cycle for this protein at the synapse. In
Figure 6 we propose a revised trafficking model, based on that
originally put forward by Cirrito and colleagues [2], which fully
reconciles our new findings to existing work - both on APP
trafficking and general synaptic physiology.
Our schematic attempts to illustrate more clearly the similarities
and interconnectedness of the trafficking pathways. In particular,
we propose that the presynaptic endosome plays a crucial role in
linking synaptic vesicle and APP cycling.
Synaptic vesicles may recycle through one of several pathways
in the presynaptic terminal. Synaptic vesicle precursors are
brought to the presynaptic terminal in transport vesicles. It is
thought that these transport vesicles undergo a round of fusion
with the plasma membrane followed by retrieval and sorting,
possibly in an endosomal intermediate to form fully functional
synaptic vesicles [47]. These vesicles are then competent to
undergo Ca
2+ mediated fusion with the plasma membrane, in
response to neuronal stimulation. Following exocytosis, vesicles are
retrieved from the plasma membrane by endocytosis. Under
physiological conditions this is thought to occur via a clathrin-
mediated [30], and presumably dynamin-dependent [48], path-
way. It is still unclear whether vesicles then lose their coats and are
recycled directly (blurring the traditional distinction between a
‘clathrin-coated’ and ‘synaptic’ vesicle), or whether they pass
through an endosomal sorting intermediate from which vesicles
are reformed using similar dynamin and clathrin-dependent
mechanisms [49]. Alternatively, it is possible that both these
pathways operate in parallel with a small proportion of vesicles
being recycled through endosomes as part of a ‘quality control
mechanism’ to ensure correct protein and lipid sorting [32];
explaining not only why a small proportion of actively recycling
vesicles contain the endosomal markers Rab5, syntaxin 13,
syxtaxin 6 and vti1a [15,32], but also why non-quantitative
immunodepletion of synaptic vesicles from brain extract, using
general vesicle markers such as synaptobrevin, may fail to detect
Figure 6. A revised model for APP trafficking in the presynaptic
terminal. The figure illustrates the various recycling pathways
proposed for synaptic vesicles in the presynaptic terminal, and how
APP recycling can be integrated. Synaptic vesicle precursors are
brought to the presynaptic terminal in transport vesicles. It is thought
that these transport vesicles undergo a round of fusion with the plasma
membrane followed by retrieval and sorting, possibly in an endosomal
intermediate, to form fully functional synaptic vesicles, which are
capable of undergoing fusion with the plasma membrane. Following
exocytosis, vesicles are retrieved from the plasma membrane by
endocytosis. Under physiological conditions this is thought to occur via
a clathrin-mediated endocytosis (CME) pathway; it is still unclear
whether vesicles lose their coats and are recycled directly, or whether
they pass through an endosomal sorting intermediate. Putative
endosomes may in fact be formed by activity dependend bulk
endocytosis (ADBE) of plasma membrane, which is thought to occur
during periods of heavy stimulation. APP trafficking at the synapse can
be integrated into our current understanding of synaptic vesicle
recycling. It is known that APP is also delivered to the presynaptic
terminal in transport vesicles. These transport vesicles either fuse with
the plasma membrane, depositing APP on the plasma membrane
surface, or alternatively they fuse with an endosomal sorting
intermediate (which we postulate is identical to that used during
recycling of synaptic vesicles). Hence, synaptic vesicles could incorpo-
rate APP when recycling through the endosome (1). During synaptic
vesicle exocytosis, APP cleavage products would then be released (2).
Slight infidelities in the endocytic process might also mean small
amounts of surface-resident APP could be endocytosed, along with
bona fide synaptic vesicle proteins. These vesicles may then recycle
directly for subsequent rounds of fusion and APP release, or pass
through the endosomal system (3). Alternatively APP may be
internalized and recycled into vesicles as a result of bulk endocytosis.
doi:10.1371/journal.pone.0018754.g006
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vesicular subsets [12,43]. Interestingly, putative endosomes may
even be initially formed by bulk endocytosis of plasma membrane,
which is thought to occur during periods of heavy stimulation; and
given the stimulus paradigms that we used in our study at least
some contribution of this bulk-endocytosis is likely [50].
APP is also thought to be trafficked to the presynaptic terminal
in transport vesicles, which interestingly seem to contain bona fide
synaptic vesicle components such as Rab3a and synaptobrevin 2
[27]. These transport vesicles are thought to either fuse with the
plasma membrane, depositing APP on the plasma membrane
surface [2], or fuse directly with an endosomal sorting interme-
diate (which we postulate is identical to that used during recycling
of synaptic vesicles) [2,51]. Hence, synaptic vesicles could acquire
APP at two points in this recycling pathway. Synaptic vesicles
could incorporate APP when recycling through the endosome (step
1); and during subsequent rounds of exocytosis APP cleavage
products would be released (step 2). Alternatively, at the plasma
membrane, slight infidelities in the endocytic process might lead to
small amounts of surface-resident APP being endocytosed, along
with bona fide synaptic vesicle proteins [32]. These vesicles could
then be recycled directly for subsequent rounds of fusion and APP
release, or pass through the endosomal system (step 3).
Alternatively, surface APP may be efficiently internalized and
recycled into vesicles as a result of activity dependent bulk
endocytosis (ADBE).
Obviously, APP needs to be proteolytically processed at some
point during trafficking. In this respect, it is interesting that our
data shows pHAPP fluorescence decreased significantly after
neuronal stimulation, consistent with proteolytic cleavage of the
construct (although we were unable to determine the exact nature
of the cleavage products due to limitations in our optical tools).
One possible explanation is cleavage of APP at the plasma
membrane surface by a-secretase. An alternative explanation,
however, is that APP is processed to Ab in synaptic vesicles, a
proposal which is supported by complementary data from
Frkyman and colleagues who recently found Ab using biochemical
methods in a somewhat cruder preparation of isolated synaptic
vesicles [13]. In this respect, it is interesting that we also found
BACE and Presenilin 1 (b and c secretases) by immunoblotting in
our synaptic vesicle fractions (although as yet we have been unable
to detect either of these proteins using mass-spectrometry -
presumably reflecting the difficulty of detecting low copy number
proteins using this technique [21]). Interestingly, this finding
implicates at least a proportion of APP positive vesicles as recycling
through the endosome; APP and BACE are conveyed to the
synaptic terminal in distinct transport vesicles [36] and hence
require such an obligate sorting intermediate. Importantly, BACE
is maximally active at pH 5.0–5.5 [52], which is close to the
luminal pH of synaptic vesicles (pH 5.7) [38]. There is also
growing evidence that cholesterol- and sphingolipid-rich mem-
brane microdomains are involved in regulating trafficking and
processing of APP, by organising the protein and its processing
enzymes into discrete domains [53,54], consistent with the high
cholesterol content of synaptic vesicles (40 mol%) [15]. Given that
independent studies show Ab production to be dependent on
alkalization (such as occurs during synaptic vesicle exocytosis)
[55,56], as well as dynamin dependent endocytosis [2], it is
tempting to speculate on the presence of a regulated, proteolytic
processing complex in synaptic vesicles. Such a complex may be
regulated by the action of the protein Reticulon 3, which was also
found in our synaptic vesicle fraction (data not shown), and is
known to inhibit the activity of BACE [57]. The presence of a
regulated processing complex may go some way to explaining why
a fraction of pHAPP remains intact and is endocytosed during our
experiments; although the possibility that our construct artificially
drives expression of pHAPP to vesicles which do not participate in
APP processing and release under normal physiological conditions
cannot be completely discounted. We are currently investigating
these aspects of APP trafficking and release.
Implications for synaptic function
Conceptually, exocytic release of APP (derivatives) from
synaptic vesicles is an attractive possibility; modulation of synaptic
function, particularly by Ab, would be possible over a time course
of seconds to minutes, in direct response to alterations in neuronal
activity. Furthermore, it appears that APP does not have to be
specifically enriched in synaptic vesicles to achieve such effects.
There is increasing evidence that even picomolar concentrations of
low n-number oligomers (particularly trimers) of Ab rapidly and
effectively inhibit NMDA receptor activity, leading to reduced
Ca
2+ influx into the dendritic spine, with subsequent spine
shrinkage and retraction leading to an overall reduction in
neuronal spine density. These effects promote long-term depres-
sion (LTD), inhibiting the induction of long-term potentiation
(LTP) by NMDA receptor-dependent signaling. As LTP is thought
to be the neural correlate of learning and memory, this would
explain why Ab can produce memory impairment when
overproduced [58].
The synaptic depressing effects of Ab are interesting when
coupled to findings indicating that increased neural activity can
drive the processing of APP to Ab [59]. These two findings led
Manilow and colleagues to suggest a negative feedback system that
could function to scale neuronal output during periods of intense
activity; the effects of such a system could be successfully localized
to discrete points of high neuronal activity by limiting the amount
of Ab released, and maximising the spatial sampling of the
dendritic spine [60]. In this model, high levels of neural activity
drive formation and release of small amounts of Ab, which then
depresses synaptic transmission reducing neural activity. Thus, an
Ab-mediated negative feedback system could be regarded as a
homeostatic process that becomes dysregulated in Alzheimer’s
disease [7], explaining why increased synaptic activity causes a
rapid and sustained increase in Ab, with brain regions that show
the highest default activity being most at risk of developing AD,
while reducing synaptic activity lowers Ab load [5]. Recognizing
that oligomer toxicity leads to synaptic dysfunction, which
presumably precedes plaque formation, also provides an explana-
tion for the observation that subtle brain dysfunction can be
detected in certain individuals many years before the appearance
of the senile plaques thought to coincide with the onset of
Alzheimer’s disease.
In the future, it will be interesting to delineate the exact
mechanisms which couple synaptic vesicle recycling with APP
trafficking, processing and secretion – with a view to developing
more effective therapeutic strategies. Indeed, pharmacologic
modulation of synaptic transmission [61] and cognitive training
[62] are already established strategies to slow down the progress of
Alzheimer’s disease. Identifying the synaptic vesicle as the
principle organelle of APP trafficking in the synapse, however,
raises the hope of developing more subtle treatments that
selectively modulate protein processing and release.
Supporting Information
Figure S1 APP is localized to synaptic vesicles as shown
by immunogold electron microscopy. Top; synaptic vesicles
isolated from rat brain were immunolabeled for synaptophysin,
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PLoS ONE | www.plosone.org 10 April 2011 | Volume 6 | Issue 4 | e18754APP or double labeled (synaptophysin 5 nm gold; APP 10 nm
gold), before viewing by negative stain electron microscopy. The
low magnification images show the synaptic vesicle preparation to
consist solely of small, homogeneously shaped vesicles, with
diameters in the range of 40–50 nm. The insets show higher
magnification images of vesicles from the same field of view. Single
labeling resulted in 99% of all vesicles immunopositive for
synaptophysin (as previously reported) and 10% of all vesicles
immunopositive for APP. Similar results were obtained with
double labeling. Bottom; negative control experiments in which
the primary antibody was omitted. For single labeling experiments
n=3; for double labeling experiment n=2. Scale bars, low
magnification 100 nm; high magnification 50 nm.
(TIF)
Figure S2 The use of pH sensitive probes to monitor
exo- and endocytosis. A) Schematic illustrating the design of
the pHAPP construct and its use in monitoring synaptic activity.
pHluorins are pH sensitive variants of GFP which can be tagged to
specific synaptic vesicle proteins and used to quantify synaptic
vesicle exo- and endocytosis. When pHluorin is attached N-
terminally to APP, it is directed towards the lumen of the synaptic
terminal, which is acidic under resting conditions. Thus the
pHluorin will be quenched (‘Initial situation’). During neuronal
stimulation, synaptic vesicles undergo fusion with the plasma
membrane, and the luminal surface becomes exposed to the more
alkaline pH of the external culture media, and the fluorescence of
the pHluorin increases (‘Exocytosis’). Following exocytosis the
fluorescence signal is reduced, either due to compensatory
endocytosis (vesicle reformation and re-acidification; ‘Endocyto-
sis’), or from loss of the N-terminal tag into the culture media as a
result of proteolytic processing (‘Cleavage’). Ammonium chloride
is membrane permeable and will neutralize the pH of the vesicle
lumen; hence, ammonium chloride can be used to report the
entire pHluorin content of the synaptic terminal (‘NH4’). B)
Schematic illustrating the use of aSyt1-cypHer antibodies to
monitor synaptic activity. Following exocytosis, the intravesicular
domain of synaptotagmin 1 is exposed to the external culture
media and can be labeled with an antibody, which is internalized
when the vesicles are retrieved. This antibody is directly
conjugated to the dye cypHer 5. CypHer fluorescence shows an
inverse profile to that of pHluorin, being fluorescent only in the
acidic environment of the vesicle (‘Initial situation’). Following
exocytosis, cypHer fluorescence is quenched in the alkaline pH of
the culture media (‘Exocytosis’). Following endocytosis, cypHer
fluorescence increases as the reformed vesicle is reacidified.
(TIF)
Methods S1
(DOC)
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